These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 11594797)
1. Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy. Chen B; Timiryasova TM; Gridley DS; Andres ML; Dutta-Roy R; Fodor I Cytokine; 2001 Sep; 15(6):305-14. PubMed ID: 11594797 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model. Chen B; Timiryasova TM; Andres ML; Kajioka EH; Dutta-Roy R; Gridley DS; Fodor I Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286 [TBL] [Abstract][Full Text] [Related]
3. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of antitumor immunity by IL-12 gene-transfected AK-5 tumor cells in vivo. Nandakumar KS; Lakshmi Rao K; Pardhasaradhi BV; Khar A Cytokines Cell Mol Ther; 1999 Mar; 5(1):7-14. PubMed ID: 10390075 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy. Stalder M; Bîrsan T; Hausen B; Borie DC; Morris RE Transpl Int; 2005 Oct; 18(10):1158-65. PubMed ID: 16162103 [TBL] [Abstract][Full Text] [Related]
6. NK cell depletion results in accelerated tumor growth and attenuates the antitumor effect of total body irradiation. Miller GM; Andres ML; Gridley DS Int J Oncol; 2003 Dec; 23(6):1585-92. PubMed ID: 14612930 [TBL] [Abstract][Full Text] [Related]
7. Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution. Jackaman C; Nelson DJ Cancer Gene Ther; 2010 Jun; 17(6):429-40. PubMed ID: 20150930 [TBL] [Abstract][Full Text] [Related]
8. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. Carson WE; Yu H; Dierksheide J; Pfeffer K; Bouchard P; Clark R; Durbin J; Baldwin AS; Peschon J; Johnson PR; Ku G; Baumann H; Caligiuri MA J Immunol; 1999 Apr; 162(8):4943-51. PubMed ID: 10202041 [TBL] [Abstract][Full Text] [Related]
9. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses. Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279 [TBL] [Abstract][Full Text] [Related]
10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
11. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. O'Malley BW; Li D; McQuone SJ; Ralston R Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147 [TBL] [Abstract][Full Text] [Related]
12. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model. Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620 [TBL] [Abstract][Full Text] [Related]
13. Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses. Portielje JE; Lamers CH; Kruit WH; Sparreboom A; Bolhuis RL; Stoter G; Huber C; Gratama JW Clin Cancer Res; 2003 Jan; 9(1):76-83. PubMed ID: 12538454 [TBL] [Abstract][Full Text] [Related]
14. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor. Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248 [TBL] [Abstract][Full Text] [Related]
15. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727 [TBL] [Abstract][Full Text] [Related]
16. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor. Lidbury BA; Ramshaw IA; Sambhi SK Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma. Lumsden AJ; Codde JP; Van der Meide PH; Gray BN Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036 [TBL] [Abstract][Full Text] [Related]
19. Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation. Mukherjee S; Haenel T; Himbeck R; Scott B; Ramshaw I; Lake RA; Harnett G; Phillips P; Morey S; Smith D; Davidson JA; Musk AW; Robinson B Cancer Gene Ther; 2000 May; 7(5):663-70. PubMed ID: 10830713 [TBL] [Abstract][Full Text] [Related]